Category: Include on Menu

  • Cryptocurrency-Linked Stocks Slide Following Moody’s U.S. Credit Rating Downgrade

    Cryptocurrency-Linked Stocks Slide Following Moody’s U.S. Credit Rating Downgrade

    Cryptocurrency-related stocks in the U.S. dropped in premarket trading, tracking the decline in Bitcoin’s price amid heightened risk aversion after Moody’s downgraded the country’s top credit rating. Notable movers included Coinbase (NASDAQ: COIN), down 3.1%, MicroStrategy (NASDAQ: MSTR), off 1.2%, and Bitfarms, which fell 4.3%. Cipher Mining (NASDAQ: CIFR) saw a significant 6.5% decline, while…

  • ICL Reports Q1 Earnings Miss, Revenue Below Expectations

    ICL Reports Q1 Earnings Miss, Revenue Below Expectations

    ICL (NYSE: ICL) announced first-quarter earnings on Monday that missed analyst estimates, with revenue declining more than anticipated. The fertilizer and specialty chemicals company’s shares fell 1.93% in pre-market trading following the report. ICL posted adjusted earnings per share (EPS) of $0.09 for the quarter, below the consensus estimate of $0.10. Revenue came in at…

  • TXNM Energy Shares Jump 9.2% Following Blackstone Buyout Agreement

    TXNM Energy Shares Jump 9.2% Following Blackstone Buyout Agreement

    Shares of TXNM Energy (NYSE: TXNM) surged 9.2% after the company announced it has agreed to be acquired by Blackstone Infrastructure (NYSE: BX) in a deal valuing TXNM Energy at $61.25 per share in cash. The transaction implies a total enterprise value of $11.5 billion, including net debt and preferred stock. The offer price represents…

  • MicroStrategy Buys More Bitcoin Amid Class Action Lawsuit Disclosure

    MicroStrategy Buys More Bitcoin Amid Class Action Lawsuit Disclosure

    MicroStrategy Incorporated (NASDAQ: MSTR) has continued expanding its bitcoin holdings while raising capital through recent stock offerings. Between May 12 and May 18, 2025, the company sold approximately 1.71 million shares of its Class A common stock, generating net proceeds of $705.7 million and leaving nearly $19 billion worth of shares available for future sale.…

  • Oil Prices Dip on U.S. Credit Downgrade, China Growth Concerns, and Iran Deal Risks

    Oil Prices Dip on U.S. Credit Downgrade, China Growth Concerns, and Iran Deal Risks

    Oil prices slipped Monday, reversing some of last week’s gains, as markets digested renewed economic uncertainty in the U.S. and China, along with signals of rising global crude supply. As of 08:15 ET (12:15 GMT), Brent crude futures for June delivery were down 0.7% at $64.93 a barrel, while West Texas Intermediate (WTI) futures dropped…

  • Walmart Stock Slides After Trump Urges Retail Giant to Absorb Tariff Costs

    Walmart Stock Slides After Trump Urges Retail Giant to Absorb Tariff Costs

    Walmart Inc. (NYSE:WMT) shares dropped 1.7% in premarket trading Monday, lagging behind the broader S&P 500 futures, which were down around 1%. The decline follows pointed remarks from former President Donald Trump, who publicly urged the retail giant to shoulder the burden of tariffs rather than raising consumer prices. The comments, posted Saturday on Trump’s…

  • TransDigm to Acquire Servotronics in $110M Deal at Massive 274% Premium

    TransDigm to Acquire Servotronics in $110M Deal at Massive 274% Premium

    Shares of Servotronics Inc. (NYSE:SVT) are set to soar after the aerospace components manufacturer agreed to be acquired by TransDigm Group Incorporated (NYSE:TDG) in a deal valued at approximately $110 million. The all-cash transaction will see TransDigm purchase Servotronics for $38.50 per share—representing a staggering 274% premium over the stock’s May 16, 2025, closing price.…

  • Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm

    Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm

    Shares of Protagenic Therapeutics (NASDAQ:PTIX) skyrocketed nearly 190% following the announcement of a merger with Phytanix Bio Inc., a move set to create a new biopharmaceutical entity named Phytanix, Inc. The combined company will focus on advancing innovative therapies targeting central nervous system (CNS) disorders, metabolic diseases, and stress-related conditions. The deal brings together a…

  • Morgan Stanley: Apple Still Under-Owned, Meta Overheld Among Big Tech Stocks

    Morgan Stanley: Apple Still Under-Owned, Meta Overheld Among Big Tech Stocks

    According to Morgan Stanley’s latest review of institutional holdings, Apple (NASDAQ:AAPL) continues to be the most under-owned large-cap tech stock among major U.S. investors, while Meta Platforms (NASDAQ:META) remains significantly overrepresented in portfolios. The analysis, based on Q1 13-F filings, reveals that although the ownership gap across the sector has narrowed somewhat, Apple still trails…

  • Regeneron Shares Climb on Acquisition of 23andMe Assets in Bankruptcy Deal

    Regeneron Shares Climb on Acquisition of 23andMe Assets in Bankruptcy Deal

    Regeneron Pharmaceuticals (NASDAQ:REGN) saw its stock rise 2% after announcing it had secured a winning bid to acquire key assets of genetic testing company 23andMe through a bankruptcy auction. The $256 million deal is poised to significantly enhance Regeneron’s capabilities in genetics-driven research and drug development. The acquisition includes 23andMe’s core business lines—such as its…